Wockhardt Announcements
Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we hereby inform you that ESG Risk Assessments & Insights Limited, a...
01 Jan, 2026 | 05:39pm • Source: BSE
Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we hereby inform you that SES ESG Research Pvt ltd has...
31 Dec, 2025 | 06:06pm • Source: BSE
In terms of provision of Regulation 30 (read with Part A of Schedule lll) and other applicable provisions of the SEBI (LODR)Regulations, 2015, we wish...
31 Dec, 2025 | 04:31pm • Source: BSE
Pursuant to Regulation 30 of SEBI Listing Regulations, please find enclosed Press Release - "European Medicines Agency Grants Accelerated Assessment to WCK 5222".
31 Dec, 2025 | 12:26pm • Source: BSE
This is to inform you that pursuant to Company''s ''Code of Conduct for regulating, monitoring and reporting trading by designated persons'', the Trading Window for...
29 Dec, 2025 | 11:16am • Source: BSE
Pursuant to Regulation 44 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Voting Results of Postal Ballot along...
15 Dec, 2025 | 06:07pm • Source: BSE
Pursuant to Regulation 44 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Voting Results of the Postal Ballot...
15 Dec, 2025 | 06:00pm • Source: BSE
In response to your captioned letter dated 02.12.2025, we would like to state that we have reviewed and verified the relevant internal records, operations and...
02 Dec, 2025 | 01:15pm • Source: BSE
The Exchange has sought clarification from Wockhardt Ltd on December 2, 2025, with reference to Movement in Volume.<BR><BR>The reply is awaited.
02 Dec, 2025 | 11:57am • Source: BSE
Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release US FDA Accepts Wockhardt s New Drug Application for Breakthrough Antibiotic Zaynich
01 Dec, 2025 | 11:53am • Source: NSE
Pursuant to Regulation 30 of Listing Regulations, please find enclosed Press Release- "US FDA Accepts Wockhardt''s New Drug Application for Breakthrough Antibiotic Zaynich".
01 Dec, 2025 | 11:38am • Source: BSE
Pursuant to Regulation 30 read with Schedule III part A para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith...
28 Nov, 2025 | 12:58pm • Source: NSE
Pursuant to Regulation 30 read with Schedule III Part A Para A of the SEBI(LODR) Regulations, 2015 we enclose herewith copy of the third newspaper...
28 Nov, 2025 | 12:52pm • Source: BSE
Pursuant to Regulation 30 of SEBI Listing Regulations, we are enclosing herewith notice of Postal Ballot dated 3rd November, 2025 along with Explanatory Statement for...
14 Nov, 2025 | 06:39pm • Source: BSE
This is with reference to your letter dated 4th November, 2025. Kindly find our response to the same attached herewith.
04 Nov, 2025 | 01:09pm • Source: BSE
The Exchange has sought clarification from Wockhardt Ltd on November 04, 2025, with reference to Movement in Volume.<BR><BR>The reply is awaited.
04 Nov, 2025 | 11:18am • Source: BSE
Pursuant to Regulation 32(6) of the SEBI(LODR) Regulations, 2015, read with Regulation 173A of SEBI (ICDR Regulations) 2018, enlcosed herewith Monitoring Agency Report for...
03 Nov, 2025 | 06:17pm • Source: BSE
Wockhardt Limited has informed the Exchange regarding a press release dated November 03, 2025, titled "Submission pursuant to Regulation 30 of SEBI (Listing Obligations and...
03 Nov, 2025 | 03:47pm • Source: NSE
Pursuant to Regulation 30 of the Listing Regulations, please find enclosed Press Release on the Un-Audited Financial Results (Standalone and Consolidated) for the quarter and...
03 Nov, 2025 | 03:31pm • Source: BSE
Pursuant to Regulation 30 of SEBI (LODR), Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting...
03 Nov, 2025 | 03:20pm • Source: BSE